West Pharmaceutical Services (NYSE:WST) Releases Earnings Results, Beats Expectations By $0.16 EPS

West Pharmaceutical Services (NYSE:WST – Get Free Report) issued its earnings results on Thursday. The medical instruments supplier reported $2.11 earnings per share for the quarter, topping analysts’ consensus estimates of $1.95 by $0.16, Briefing.com reports. The business had revenue of $753.80 million during the quarter, compared to analyst estimates of $755.71 million. West Pharmaceutical […]

Related Keywords

United States ,America ,Asia Pacific ,Silji Abraham ,Keycorp ,O Shaughnessy Asset Management ,Kraft Davis Associates ,Journey Strategic Wealth ,Earnings History For West Pharmaceutical Services ,News Ratings For West Pharmaceutical Services Daily ,Services Inc ,Institutional Trading Of West Pharmaceutical Services ,Services Price Performance ,West Pharmaceutical Services ,Get Free Report ,Pharmaceutical Services ,Mark Green ,West Pharmaceutical ,Shaughnessy Asset Management ,Middle East ,Proprietary Products ,West Pharmaceutical Services Daily ,Nyse Wst ,Wst ,Medical ,95530610 ,Earnings ,